[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$2975b
West Pharmaceutical's Q2 earnings beat expectations, leading to a raised outlook. The stock is likely to see positive movement due to strong financial performance.
About $2975b
A financial topic related to West Pharmaceutical.
Engagements: X #
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: XXX
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-06-11
1-Year Low: X on 2025-05-20
| Social Network | X |
|---|---|
| Engagements | X |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Month: X +100%
1-Year High: X on 2025-05-15
1-Year Low: X on 2025-05-18
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $2975b in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X +50%
1-Year High: X on 2025-05-15
1-Year Low: X on 2025-05-18
Top topics mentioned In the posts about $2975b in the last XX hours
javascript, $2945b, $306b, $304b
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$WST West Pharmaceutical Q2'25 Earnings Beat & Raised Outlook 💥 via Revenue: $766.5M (+9.2% YoY) vs. $725.3M est. 🟢 Adj. EPS: $XXXX (+21% YoY) vs. $XXXX est. 🟢 Organic Sales Growth: +6.8% YoY 📈 FY25 Guidance Raised: Revenue: $3.04B$3.06B (Prior: $2.945B$2.975B) EPS: $6.65$6.85 (Est. $6.27) 🟢 Organic Growth: 3%3.75% (Prior: 2%3%) FX Tailwind: +$59M rev / +$0.27 EPS 🧪 Proprietary Products (Q2): Rev: $619.8M (+10.7% YoY) High-Value Components: +11.3% Delivery Devices: +30.0% Standard Products: +0.4% 🏭 Contract-Manufactured Products: Rev: $146.7M (+3.0% YoY) Growth led by self-injection"
@overnight_stock on X 2025-07-24 11:42:05 UTC XXX followers, XX engagements